A highly sensitive fluorescent light-up probe for real-time detection of the endogenous protein target and its

Junlong Geng1, Walter L Goh, Chongjing Zhang

  • 1Institute of Materials Research Engineering, A*STAR, 3 Research Link, Singapore 117602. tanyn@imre.a-star.edu.sg.

Insights

Scientists developed a novel fluorescent probe for real-time detection of Mdm2 protein in live cells. This tool aids in cancer diagnostics and drug discovery by enabling precise monitoring of Mdm2 interactions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Real-time detection of cancer-related biomolecular interactions in live cells is crucial for diagnostics and drug screening.
  • Mdm2 is a key negative regulator of the p53 tumor suppressor protein, making it a significant target in cancer research.

Purpose of the Study:

  • To develop a target-specific fluorescent light-up probe for cellular detection of Mdm2.
  • To enable real-time live cell imaging and quantitative detection of Mdm2 and its antagonism.
  • To demonstrate the probe's utility in screening drug candidates that inhibit the p53-Mdm2 interaction.

Main Methods:

  • Conjugation of a fluorogen (TPECM) with aggregation-induced emission properties to a p53-derived peptide (12.1Pep) targeting Mdm2.
  • Development of a cell-permeable, turn-on fluorescent probe (TPECM-12.1Pep) with high specificity for Mdm2.
  • In vitro and cellular assays using a model compound (Nutlin-3a) to validate probe performance and drug screening capabilities.
  • Monitoring probe activity in cells using fluorescently activated cell sorting (FACS).

Main Results:

  • The developed probe (TPECM-12.1Pep) exhibits turn-on fluorescence properties, being nearly non-fluorescent in isolation but highly emissive upon binding to Mdm2.
  • The probe allows for real-time live cell imaging and quantitative detection of Mdm2.
  • The probe successfully facilitated the screening of p53-Mdm2 inhibiting drug candidates both in vitro and in cellular models.
  • Probe activity was accurately monitored in cells via FACS.

Conclusions:

  • A novel, target-specific fluorescent light-up probe for Mdm2 has been successfully developed.
  • The probe enables real-time monitoring and quantitative detection of Mdm2 in live cells.
  • This technology holds significant potential for accelerating drug discovery, clinical diagnostics, and fundamental cell biology research.